# PrevaCept Infection Control

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prevacept-infection-control

- Industry: Medical Devices & Equipment
- Headquarters: Broomfield, US
- Website: www.prevacept.com
- Total disclosed funding: $18M
- Latest round: Series B (Sep 12, 2017)
- Investors on record: 8

## About

PrevaCept Infection Control, Inc. focuses on creating advanced software solutions to enhance operational efficiency in healthcare, logistics, and financial services, improving data management and stakeholder communication.Founded in 2006 and headquartered in Broomfield, US, PrevaCept Infection Control, Inc. specializes in software applications designed to optimize processes across various sectors. The firm has completed 9 deals and raised a total of USD 0.99 mn, with its latest funding round being the Series B, which also amounted to USD 0.99 mn. The company received investments from Ohio TechAngels - DUP and Rev1 Ventures. No significant pivots in business strategy have been mentioned.PrevaCept Infection Control, Inc. develops innovative software applications that enhance operational efficiency in sectors like healthcare, logistics, and financial services. Launched in 2023, these solutions are designed to streamline processes, improve data management, and facilitate communication among stakeholders, serving a diverse client base that includes hospital networks and supply chain firms.The company operates on a subscription-based revenue model, where clients enter annual contracts for tiered access to its software applications. This model supports ongoing client needs and allows for upgrades as requirements evolve, while strategic partnerships further enhance revenue streams by integrating solutions into existing platforms.PrevaCept Infection Control, Inc. plans to launch new products designed to further enhance operational efficiency, although specific release dates are not mentioned. The firm is targeting expansion into new geographic markets, particularly in North America and Europe, to increase its client base by the end of 2024. Recent funding will be utilized to support these growth initiatives, as Rev1 Ventures has exited its stake in the company.

## Funding rounds

- Series B, Sep 12, 2017 — Ohio TechAngels - DUP, Rev1 Ventures
- Series B, Feb 23, 2017, $1M — Ohio TechAngels - DUP, Rev1 Ventures
- Series C, Sep 10, 2014, $11M — Venture Investors, Charter Life Sciences
- Seed, Oct 19, 2011, $0.1M — JumpStart
- Series B, Jul 26, 2010, $3.1M — Charter Life Sciences, Early Stage Partners, North Coast Ventures, Rev1 Ventures
- Series A, May 2, 2008, $2.4M — JumpStart, North Coast Ventures, Case Technology Ventures, Rev1 Ventures
- Seed, Aug 22, 2007, $0.3M — JumpStart
- Seed, Apr 24, 2006, $0.3M — Case Technology Ventures

## Investors

- Case Technology Ventures (https://capitalatlas.ai/funds/case-technology-ventures) — Seed, Series A
- JumpStart (https://capitalatlas.ai/funds/jumpstart) — Seed, Series A
- North Coast Ventures (https://capitalatlas.ai/funds/north-coast-ventures) — Series A, Series B
- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Series A, Series B
- Charter Life Sciences (https://capitalatlas.ai/funds/charter-life-sciences) — Series B, Series C
- Early Stage Partners (https://capitalatlas.ai/funds/early-stage-partners) — Series B
- Venture Investors — Series C
- Ohio TechAngels - DUP — Series B